Xydalba 500 mg (Dalbavancin (Dalbavancin Hydrochloride) POWDER FOR SOLUTION) 500 MG

Xydalba 500 mg is a powder for solution containing dalbavancin hydrochloride, used for intravenous administration. This antibiotic is designed to treat bacterial infections, offering a convenient dosing regimen.

Strength

500 MG

Manufacturer / TM Owner

ENDO OPERATIONS LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xydalba 500 mg is primarily used for the treatment of bacterial infections. Dalbavancin, the active ingredient, is effective against a range of gram-positive bacteria. This medication is often prescribed for conditions where prolonged antibiotic therapy is necessary, such as skin and soft tissue infections. Patients may wonder, 'What is Xydalba used for?' and the answer lies in its broad-spectrum activity against resistant bacteria.

Side Effects

Common effects of Xydalba 500 mg may include infusion-related reactions such as flushing, nausea, and headache. Some patients might experience mild to moderate side effects, but these are generally well-tolerated. The medication works by interfering with bacterial cell wall synthesis, which helps to combat infections effectively.

Precautions & Warnings

Xydalba 500 mg should be handled with care, ensuring proper reconstitution and administration by healthcare professionals. Patients with a history of allergic reactions to dalbavancin or similar antibiotics should exercise caution. It is important to follow the prescribed dosage and administration guidelines to minimize potential risks.

Avoid Interactions

Xydalba 500 mg may interact with other medications, particularly those that affect liver enzymes. Patients should inform their healthcare provider about all current medications, including over-the-counter drugs and supplements. Alcohol and certain CYP inhibitors might also influence the effectiveness of dalbavancin, so it is advisable to discuss potential interactions with a healthcare professional.

Frequently Asked Questions

Xydalba is used to treat bacterial infections, particularly those caused by gram-positive bacteria.

Xydalba is administered intravenously as a powder for solution, typically prepared and given by healthcare professionals.

Common side effects may include infusion-related reactions such as flushing, nausea, and headache.

Patients should consult their healthcare provider about potential interactions with other medications.

Xydalba is specifically designed to treat bacterial infections caused by gram-positive bacteria.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.